Vivaldis Atovaquin 250mg (Atovaquone USP) Antiprotozoal Tablets for Dogs & Cats (10 Tablets)

Select Variant: 1

Description

Provide targeted, lifesaving therapeutic intervention against stubborn tick-borne protozoal parasites with Vivaldis Atovaquin 250mg Tablets for Dogs and Cats, available online at PetMitra. Formulated by Vivaldis Animal Health, Atovaquin delivers Atovaquone USP (250 mg), an advanced hydroxynaphthoquinone antiprotozoal compound engineered specifically for intraerythrocytic protozoal infections that fail to respond to traditional therapies. In canine clinical medicine, tick fever caused by Babesia gibsoni (small piroplasm) poses a serious therapeutic challenge due to its frequent resistance to conventional antibabesial drugs like imidocarb dipropionate or diminazene aceturate. Untreated or inadequately managed infections lead to severe hemolytic anemia, profound thrombocytopenia (low platelet counts), splenomegaly, and organ failure. Similarly, feline cytauxzoonosis (Cytauxzoon felis), transmitted by ticks, is an acute, rapidly progressive, and historically fatal disease in cats. Vivaldis Atovaquin works via a targeted cellular mechanism: Selective Mitochondrial Inhibition: Atovaquone binds selectively to the protozoal cytochrome bc₁ complex (Complex III) within the parasite's electron transport chain. This blocks pyrimidine synthesis and halts cellular ATP production, effectively starving and destroying the intraerythrocytic parasite. Minimal Host Toxicity: Mammalian mitochondrial cytochrome complexes possess structural differences that make them largely insensitive to Atovaquone, ensuring powerful parasitological clearance with minimal adverse effects on your pet's healthy organs. Standard-of-Care Combination Therapy: Widely prescribed by veterinary internists in conjunction with Azithromycin to achieve PCR-negative status and prevent disease relapse.